Ha Tay Pharmaceutical JSC (HNX:DHT)

Market Cap	7.00T
Revenue (ttm)	2.16T
Net Income (ttm)	72.94B
Shares Out	82.34M
EPS (ttm)	885.79
PE Ratio	95.96
Forward PE	n/a
Dividend	1,000.00 (1.18%)
Ex-Dividend Date	Oct 30, 2024

Volume	13,602
Average Volume	22,316
Open	85,600
Previous Close	87,000
Day's Range	85,000 - 87,700
52-Week Range	65,000 - 110,900
Beta	0.22
RSI	48.23
Earnings Date	Aug 7, 2025

About Ha Tay Pharmaceutical JSC

Ha Tay Pharmaceutical JSC manufactures, trades in, imports, and exports medicines, chemical raw materials for medicine, medicinal materials, and medical equipment. In addition, the company provides medicinal products manufacturing services; and import-export authorization services, as well as supplies pharmaceutical ingredients for enterprises. The company was founded in 1965 and is based in Hanoi, Vietnam.

• Industry: Pharmaceutical Preparations
• Founded: 1965
• Country: Vietnam
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: DHT

Financial Performance

In 2024, Ha Tay Pharmaceutical JSC's revenue was 2.09 trillion, an increase of 4.35% compared to the previous year's 2.00 trillion. Earnings were 71.77 billion, a decrease of -15.62%.